LY3437943

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for LY3437943, covering 2023-07-03 to 2026-03-12. Get the full timeline:

Most recent: Clinical Trial Update: Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight [Phase 2]